Zurcher Kantonalbank (Zurich Cantonalbank) Kezar Life Sciences, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$3.13 - $7.31 $4,450 - $10,394	-1,422 Reduced 16.58%	7,156 $22,000
Q4 2022 Feb 01, 2023	SELL	$6.39 - $8.8 $29,068 - $40,031	-4,549 Reduced 34.65%	8,578 $60,000
Q3 2022 Nov 09, 2022	BUY	$7.99 - $10.75 $91,109 - $122,582	11,403 Added 661.43%	13,127 $113,000
Q2 2022 Aug 09, 2022	SELL	$4.58 - $17.13 $668 - $2,500	-146 Reduced 7.81%	1,724 $14,000
Q1 2022 Apr 21, 2022	SELL	$12.3 - $18.33 $45,620 - $67,985	-3,709 Reduced 66.48%	1,870 $31,000
Q4 2021 Feb 01, 2022	BUY	$7.44 - $16.72 $41,507 - $93,280	5,579 New	5,579 $93,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

Suvretta Capital Management, LLC New York, NY

7.17M
Shares

$47 Million
0.22% of portfolio
Avidity Partners Management LP Dallas, TX

5.03M
Shares

$33 Million
0.24% of portfolio
Tang Capital Management LLC San Diego, CA

3.64M
Shares

$23.9 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.74M
Shares

$18 Million
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.51M
Shares

$16.5 Million
0.33% of portfolio

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $449M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account